Orchid Pharma allots 4.46 cr shares to Dhanuka Labs shareholders

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

ORCHPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹987.30

prior close

₹990.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-1.9% vs market

Pharmaceuticals peers, median of 163sector+1.0%-1.5% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.4

15m

-0.1

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+1.3-1.9+1.0-1.5

Next day

+0.4+1.8-1.4+0.8-0.4

+0.6+3.1-2.5+0.2+0.4

+0.3+3.5-3.2+0.7-0.5

+1.9+3.5-1.6+1.4+0.5

+9.9+3.4+6.5+1.1+8.8

+7.9+3.6+4.2+1.5+6.4

15d

+5.2+4.9+0.4+0.8+4.4

-4.6+4.4-9.0+1.7-6.3

-2.2+2.9-5.1+1.9-4.0

-14.4-3.5-11.0-2.8-11.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Orchid Pharma's Board approved allotment of 4,45,86,052 equity shares of Rs 10 each to eligible shareholders of Dhanuka Laboratories under the amalgamation scheme that became effective on July 10, 2026. Record date was July 23, 2026. Post-allotment, paid up share capital stands at about Rs 59.88 crore divided into 5.98 crore shares, with new shares to rank equally with existing ones and list on BSE and NSE. Cross holding of Dhanuka Labs was also cancelled.

Likely market impact

Significant dilution for existing Orchid Pharma shareholders as 4.46 crore new shares nearly triple the share count. Watch for price adjustment after listing.